Novel Treatment Strategies to Improve Outcomes in Patients with Relapsing Remitting Multiple Sclerosis
Program Overview
This CME program, derived from content presented at the Advanced Curriculum for Multiple Sclerosis 2020 Course in West Palm Beach, Florida, will highlight novel treatment strategies to improve outcomes in patients with relapsing remitting multiple sclerosis (RRMS). The expert faculty will review the science of relapsing remitting multiple sclerosis, including risk mitigation and the pharmacokinetics of current therapeutic ...
View Course
Novel S1P-Based Therapeutics to Improve Outcomes and Reduce Disability in Patients with Relapsing Multiple Sclerosis
Program Overview
This CME program, derived from content presented at the Advanced Curriculum for Multiple Sclerosis 2020 Course in West Palm Beach, Florida, will highlight novel S1P-based therapeutics to improve outcomes and reduce disability in patients with relapsing multiple sclerosis. The expert faculty will review the recent science of newer S1P-based therapeutics for the treatment of patients with relapsing multiple ...
View Course
A Scientific Overview of the Pharmacological and Non-Pharmacological Treatment Strategies for Parkinson’s Disease
Program Overview
This continuing medical education program will highlight recent advances in the treatment and management of patients with Parkinson’s disease (PD), including data presented at the International Congress of Parkinson’s Disease and Movement Disorders (MDS) 2019 in Nice, France. The three expert faculty will review the pathophysiology of Parkinson’s disease, as well as best practices for early detection and ...View Course
Applying Novel Pharmacotherapies to Improve Outcomes in Patients with Acute Leukemia
Program Overview
This CME/CE activity will highlight recent data for the treatment and management of acute leukemia, including information presented at the American Society of Hematology Annual Meeting in Orlando, Florida. The expert faculty, chaired by Eytan M. Stein, MD, will first discuss the pathophysiology of acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL), reviewing diagnostic criteria and comorbidities ...View Course
Advanced Strategies to Improve CVD Outcomes in Patients with Chronic Coronary Artery Disease and Peripheral Artery Disease
Program Overview
This CME/CE program, derived from content presented at the 2019 American Heart Association Scientific Sessions in Philadelphia, Pennsylvania, will highlight advanced strategies for improving cardiovascular disease (CVD) outcomes in patients with chronic coronary artery disease (CAD) and peripheral artery disease (PAD). The expert faculty, chaired by Dr. Christopher P. Cannon, will first provide an introduction and state of ...View Course
Intensive Antiplatelet Therapy to Improve Outcomes in Patients with Acute Coronary Syndrome
Program Overview
This CME program will highlight recent advances in intensive antiplatelet therapy to improve outcomes in patients with acute coronary syndrome (ACS). The expert faculty, led by Dr. Christopher P. Cannon, will review platelet inhibition science as well as unmet needs in ACS. Following, recent clinical trial data, including outcomes data, will be analyzed and clinical relevance debated in ...View Course
Scientific Updates on Antiplatelet Therapies for the Management of Patients with Acute Coronary Syndrome
Program Overview
This continuing education activity is derived from content presented at the 2019 ASHP Midyear Clinical Meeting & Exhibition in Las Vegas, Nevada. The program will highlight recent advances in antiplatelet therapeutics for acute coronary syndrome. The expert faculty will analyze current guidelines and provide insight into best approaches for developing effective patient-specific treatment plans that include the clinical ...View Course
An In-Depth Overview of CGRP Inhibitors & Therapeutic Implementation to Improve Patient Outcomes
Program Overview
This CME activity will review recent advances in the improvement CGRP Inhibitors & Therapeutic Implementation as presented at the American Headache Society (AHS) 2019 Philadelphia, PA. The expert faculty will discuss the immunologic and pathogenic mechanisms of CGRP as well as strategies for implementation of novel CGRP inhibitors into patient-specific treatments. The faculty will also analyze safety, efficacy, ...View Course
Clinical Updates for the Optimal Management of Patients with Inflammatory Bowel Disease
Program Overview
This CME activity will review recent advances in the management of patients with Inflammatory Bowel Disease (IBD) as presented at the Digestive Disease Week (DDW) 2019 in San Diego, CA. The expert faculty will discuss the science of the inflammatory cascade as well as review recent clinical trial data for IBD treatments. The faculty will also discuss strategies ...View Course
An In-Depth Analysis of Asthma and Emerging Pharmacotherapies for Effective Patient Management
Program Overview
This CME program was derived from content presented at the Eastern Pulmonary Conference 2019 Annual Meeting in Palm Beach, Florida. The expert faculty, Dr. Sidney Braman, will review the pathophysiology and disease burden of asthma to improve patient management. Next, he will delve into the subtypes of asthma and analyze clinical data of novel pharmacotherapies to determine treatment ...View Course
